INNOGEN-B Shares Extend Losses as Lock-Up Period Nears End

Stock News05-14

INNOGEN-B (02591) saw its share price decline by over 5%, continuing a downward trend after a significant surge earlier in the week. The stock had jumped more than 32% on heavy volume this past Monday but has retreated over the following three sessions. At the time of writing, the stock was down 5.32% to HK$13.7, with a turnover of HK$21.69 million.

The recent movement comes ahead of the expiration of the lock-up period for the company's cornerstone investors. According to a prior company announcement, the lock-up period is set to end on May 14, 2026, with the related shares becoming freely tradable on May 15. The cornerstone investors collectively hold 4.201 million shares.

Financially, INNOGEN-B reported revenue of RMB 132 million for the 2025 fiscal year, primarily generated from sales of its product, ESUPAGLUTIDE α, in China. The company recorded a net loss of RMB 341 million, representing a year-on-year expansion of 95.41%. Research and development expenses for the period doubled to RMB 206 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment